Investigation of the 5-hydroxytryptamine Receptor Mechanism Mediating the Short-circuit Current Response in Rat Colon

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 1991 Apr 1

PMID 1855112

Citations 13

Authors

K T Bunce

C J Elswood

M T Ball

Affiliations

Soon will be listed here.

Abstract

1. 5-Hydroxytryptamine (5-HT) stimulated an increase in short-circuit current (SCC) in rat isolated colonic mucosa with an EC50 value of approximately 4 microM. The purpose of the present study was to investigate the 5-HT receptor mechanism(s) involved in this response. 2. The relatively selective 5-HT receptor agonists 5-carboxamidotryptamine (5-CT) and alpha-methyl-5-HT stimulated SCC and were 6 to 8 times less potent than 5-HT. 2-Methyl-5-HT was inactive both as an agonist and an antagonist. 3. The following compounds produced no significant inhibition of the SCC response to 5-HT: ketanserin (1 microM), methysergide (1 microM), methiothepin (0.3 microM), GR38032F (0.3 microM), tetrodotoxin (0.3 microM) and sulpiride (1 microM). 4. Both metoclopramide (3 and 10 microM) and cisapride (0.1 and 1 microM) inhibited the SCC responses to 5-HT in a concentration-related manner, and the higher doses similarly inhibited the responses to 5-CT. With both agonists the inhibitory effects of metoclopramide and cisapride were insurmountable. However, these inhibitory actions appeared to be selective since neither metoclopramide nor cisapride affected the basal SCC or the SCC response to prostaglandin E2. 5. The SCC responses to 5-HT and 5-methoxytryptamine were selectively inhibited by ICS205-930 at 3 microM, and respective pKB values of 6.0 and 6.6 were calculated. 6. It is concluded that 5-HT stimulates an SCC response in rat colon via a receptor mechanism that cannot be clearly identified as 5-HT1-like, 5-HT2 or 5-HT3. This receptor is selectively antagonized by ICS 205-930 and by the benzamides, metoclopramide and cisapride. The 5-HT receptor in rat colon therefore exhibits some of the properties associated with the so-called 5-HT4 receptor.

Citing Articles

Investigations of Piperazine Derivatives as Intestinal Permeation Enhancers in Isolated Rat Intestinal Tissue Mucosae.

Stuettgen V, Brayden D AAPS J. 2020; 22(2):33.

PMID: 31989362 DOI: 10.1208/s12248-020-0416-9.

An Assessment of the Permeation Enhancer, 1-phenyl-piperazine (PPZ), on Paracellular Flux Across Rat Intestinal Mucosae in Ussing Chambers.

Bzik V, Brayden D Pharm Res. 2016; 33(10):2506-16.

PMID: 27387171 DOI: 10.1007/s11095-016-1975-4.

Luminal 5-HT stimulates colonic bicarbonate secretion in rats.

Kaji I, Akiba Y, Said H, Narimatsu K, Kaunitz J Br J Pharmacol. 2015; 172(19):4655-70.

PMID: 26061462 PMC: 4594270. DOI: 10.1111/bph.13216.

Human colonic anti-secretory activity of the potent NK(1) antagonist, SR140333: assessment of potential anti-diarrhoeal activity in food allergy and inflammatory bowel disease.

Moriarty D, Goldhill J, Selve N, ODonoghue D, Baird A Br J Pharmacol. 2001; 133(8):1346-54.

PMID: 11498521 PMC: 1621146. DOI: 10.1038/sj.bjp.0704194.

Pharmacological characterization of 5-HT4 receptors mediating relaxation of canine isolated rectum circular smooth muscle.

Prins N, Van Haselen J, Lefebvre R, Briejer M, Akkermans L, Schuurkes J Br J Pharmacol. 1999; 127(6):1431-7.

PMID: 10455293 PMC: 1760667. DOI: 10.1038/sj.bjp.0702665.

References

ERSPAMER V . Pharmacology of indole-alkylamines. Pharmacol Rev. 1954; 6(4):425-87. View

Donowitz M, Binder H . Jejunal fluid and electrolyte secretion in carcinoid syndrome. Am J Dig Dis. 1975; 20(12):1115-22. DOI: 10.1007/BF01070754. View

Dumuis A, Sebben M, Bockaert J . The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons. Naunyn Schmiedebergs Arch Pharmacol. 1989; 340(4):403-10. DOI: 10.1007/BF00167041. View

Cooke H, Carey H . Pharmacological analysis of 5-hydroxytryptamine actions on guinea-pig ileal mucosa. Eur J Pharmacol. 1985; 111(3):329-37. DOI: 10.1016/0014-2999(85)90639-9. View

Bradley P, Engel G, Feniuk W, Fozard J, Humphrey P, Middlemiss D . Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology. 1986; 25(6):563-76. DOI: 10.1016/0028-3908(86)90207-8. View

Moriarty K, Higgs N, Woodford M, Warhurst G, Turnberg L . Inhibition of the effect of serotonin on rat ileal transport by cisapride: evidence in favour of the involvement of 5-HT2 receptors. Gut. 1987; 28(7):844-8. PMC: 1433095. DOI: 10.1136/gut.28.7.844. View

Scholtysik G . Evidence for inhibition by ICS 205-930 and stimulation by BRL 34915 of K+ conductance in cardiac muscle. Naunyn Schmiedebergs Arch Pharmacol. 1987; 335(6):692-6. DOI: 10.1007/BF00166988. View

Feniuk W, Humphrey P, Perren M, WATTS A . A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists. Br J Pharmacol. 1985; 86(3):697-704. PMC: 1916725. DOI: 10.1111/j.1476-5381.1985.tb08948.x. View

Nelson D, Thomas D . [3H]-BRL 43694 (Granisetron), a specific ligand for 5-HT3 binding sites in rat brain cortical membranes. Biochem Pharmacol. 1989; 38(10):1693-5. DOI: 10.1016/0006-2952(89)90319-5. View

10.

Clarke D, Craig D, Fozard J . The 5-HT4 receptor: naughty, but nice. Trends Pharmacol Sci. 1989; 10(10):385-6. DOI: 10.1016/0165-6147(89)90177-6. View

11.

Kenakin T . The classification of drugs and drug receptors in isolated tissues. Pharmacol Rev. 1984; 36(3):165-222. View

12.

Humphrey P . Peripheral 5-hydroxytryptamine receptors and their classification. Neuropharmacology. 1984; 23(12B):1503-10. DOI: 10.1016/0028-3908(84)90094-7. View

13.

Baird A, Cuthbert A . Neuronal involvement in type 1 hypersensitivity reactions in gut epithelia. Br J Pharmacol. 1987; 92(3):647-55. PMC: 1853686. DOI: 10.1111/j.1476-5381.1987.tb11368.x. View

14.

Branchek T, Gershon M . Development of neural receptors for serotonin in the murine bowel. J Comp Neurol. 1987; 258(4):597-610. DOI: 10.1002/cne.902580409. View

15.

ALPHIN R, Proakis A, Leonard C, Smith W, DANNENBURG W, Kinnier W . Antagonism of cisplatin-induced emesis by metoclopramide and dazopride through enhancement of gastric motility. Dig Dis Sci. 1986; 31(5):524-9. DOI: 10.1007/BF01320319. View

16.

Beubler E, Coupar I, Hardcastle J, Hardcastle P . Stimulatory effects of 5-hydroxytryptamine on fluid secretion and transmural potential difference in rat small intestine are mediated by different receptor subtypes. J Pharm Pharmacol. 1990; 42(1):35-9. DOI: 10.1111/j.2042-7158.1990.tb05345.x. View

17.

Bockaert J, Sebben M, Dumuis A . Pharmacological characterization of 5-hydroxytryptamine4(5-HT4) receptors positively coupled to adenylate cyclase in adult guinea pig hippocampal membranes: effect of substituted benzamide derivatives. Mol Pharmacol. 1990; 37(3):408-11. View

18.

Craig D, Clarke D . Pharmacological characterization of a neuronal receptor for 5-hydroxytryptamine in guinea pig ileum with properties similar to the 5-hydroxytryptamine receptor. J Pharmacol Exp Ther. 1990; 252(3):1378-86. View

19.

Gaginella T, Rimele T, Wietecha M . Studies on rat intestinal epithelial cell receptors for serotonin and opiates. J Physiol. 1983; 335:101-11. PMC: 1197341. DOI: 10.1113/jphysiol.1983.sp014522. View

20.

Racusen L, Binder H . Effect of prostaglandin on ion transport across isolated colonic mucosa. Dig Dis Sci. 1980; 25(12):900-4. DOI: 10.1007/BF01308038. View